Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Signatures of Lithium Treatment: Current Knowledge

30 Jul 2018

Abstract excerpt

Lithium (Li) is the key mood stabilizer in the prevention of mood recurrences and suicide in bipolar disorders. However, only one-third of patients become asymptomatic with Li treatment, and to date, no clinical markers can predict this response variability. Li is a multitargeting drug, complicating an understanding of its mechanisms of action. The present article reviews Li's various biological effects,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to Genetic Syndromes and Imprinting
Share to Genetics and Neurodevelopmental Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30060262
DOI: 10.1055/a-0650-4820

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Signatures of Lithium Treatment: Current KnowledgePMID 30060262Read ↗

Lithium Pharmacogenetics: Where Do We Stand?Semantic proximity Read ↗

Lithium response in bipolar disorder: Genetics, genomics, and beyondSemantic proximity Read ↗

Molecular actions and clinical pharmacogenetics of lithium therapySemantic proximity Read ↗

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing TreatmentSemantic proximity Read ↗

Prediction of Prophylactic Response to Lithium in Bipolar Disorder Using Acute Antidepressant Non-Response to Ketamine: A Scoping ReviewSemantic proximity Read ↗

Genetic and Epigenetic Markers of Lithium ResponseSemantic proximity Read ↗

Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.Semantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Exploring lithium’s transcriptional mechanisms of action in bipolar disorder: a multi-step studySemantic proximity Read ↗

Pharmacogenomics of Lithium Response in Bipolar DisorderSemantic proximity Read ↗

Lithium: a key to the genetics of bipolar disorderSemantic proximity Read ↗

The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.